The Washington Cancer Institute, located in Washington D.C., is a regional and national leader in the treatment of advanced cancer care, including mesothelioma. Patients can expect to receive the most technologically advanced care and treatment along with a personalized experience. The Washington Cancer Institute treats pleural, peritoneal and other asbestos-related cancers but is best known for managing peritoneal mesothelioma.
About Washington Cancer Institute
The Washington Cancer Institute is a part of the MedStar Washington Hospital Center, which is one of the largest hospitals in the United States. MedStar Washington Hospital Center is consistently recognized on U.S. News and World Report “Best Hospitals” list among many other awards and honors.
The Washington Cancer Institute was founded in 1992 and has earned a reputation of being the leading cancer center in the Washington D.C. region. It has become a model for comprehensive, multidisciplinary care for cancer centers across the nation.
The staff at Washington Cancer Institute take a personalized, patient-centered approach when it comes to cancer care. The center specializes in the most advanced techniques in medical, surgical and radiation oncology.
Asbestos and Mesothelioma at Washington Cancer Institute
Those with asbestos-related cancers can expect a wide-range of cutting-edge therapies at the Washington Cancer Institute. Asbestos lung cancer patients will be seen at the Center for Comprehensive Lung Health to see an experienced team of lung specialists.
Regarding mesothelioma, the Washington Cancer Institute is best known for its treatment of peritoneal mesothelioma.
A world-renowned expert, Dr. Paul Sugarbaker, has pioneered successful treatment of peritoneal mesothelioma with his signature surgical technique known as the Sugarbaker Procedure, which is a combination of cytoreductive surgery and targeted heated chemotherapy.
Washington Cancer Institute Location
MedStar Washington Hospital Center
110 Irving Street NM
Washington DC 20010
Patient Care Experience
At the Washington Cancer Institute, patients can expect to receive a personalized approach to their mesothelioma care and treatment.
The center provides advanced care in every oncology specialty and aims to use the newest therapies offered through clinical trials. The multidisciplinary team works together to determine the best treatment for the patient. Patients and their families can also expect comprehensive nurse navigator and social work services to support them before, during, and after cancer treatment care.
Navigating cancer treatment is a life-changing event for patients and families, and the staff at Washington Cancer Institute is dedicated to providing support and compassion.
The Washington Cancer Institute is dedicated to providing the latest in technological advances, whether it is 3D imaging, CT or PET scanning. This center is one of the most technologically advanced in the nation allowing them to accurately diagnose and effectively treat cancer.
Radiation Oncology Specialists
- Pamela Randolph-Jackson, MD
- Adedamola B. Omogbehin, MD
Thoracic Surgery Specialists
- Marc Margolis, MD
Surgical Oncology Specialists
- Chukwuemeka Ihemelandu, MD
- Mark Alan Steves, MD
- Paul Sugarbaker, MD
Dr. Paul Sugarbaker
Dr. Sugarbaker is the director of the Center for Surgical Oncology at the Washington Cancer Institute where he is the leading surgeon for treating peritoneal mesothelioma. He is the older brother of the prominent surgeon for pleural mesothelioma patients, the late Dr. David Sugarbaker of Baylor College of Medicine Lung Institute.
Treatment Options at Washington Cancer Institute
The Washington Cancer Institute takes a multidisciplinary approach when it comes to treating mesothelioma. Patients with pleural, peritoneal or other forms of mesothelioma will consult with a group of experts to determine the most appropriate treatment. Multiple modalities may be used including medical, radiation or surgical therapy along with supportive care.
Mesothelioma Justice Network Brief
The Washington Cancer Institute launched the Peritoneal Surface Malignancies program in 1993 in order to better serve those with mesothelioma in the peritoneum as well as other complex cancers of the abdomen and pelvis. While a peritoneal surface malignancy diagnosis used to have a dire prognosis, many patients treated at the Washington Cancer Institute now live full, active lives. In fact, a prospective review of patients with peritoneal mesothelioma treated by the Sugarbaker Procedure revealed a median survival of 67 months.
The Washington Cancer Institute offers a number of modalities for surgery for peritoneal surface malignancies:
- Cytoreductive Surgery: As much of the tumor is removed as possible. It may require removing parts of other affected organs as well, like the bowels, liver, gallbladder, spleen, pancreas and stomach. For women, it may also mean removing the reproductive organs. This approach, known as the Sugarbaker Procedure, is often paired with hyperthermic intraperitoneal chemotherapy (HIPEC).
- Hemicolectomy: Removes part of the colon.
- Peritonectomy: Strips away the peritoneum to remove tumors from the lining of the peritoneal cavity.
Depending on the type of peritoneal surface malignancy and how far it extends, patients may need chemotherapy before or after surgery.
- Before Surgery (Neoadjuvant): If the tumor is growing quickly, chemotherapy may be needed before surgery. It’s typically taken at home for 2 months beforehand, with a month to recover before the surgery.
- After Surgery: Some patients may also need chemotherapy following surgery, but only if the cancer is considered high-grade.
Doctors give HIPEC immediately after a peritonectomy or cytoreductive surgery while still in the operating room. Doctors heat up chemotherapy drugs to make them more powerful and then soak the surgical site in the abdomen directly. HIPEC kills any remaining cancer cells straight at the cancer source without significantly affecting the rest of the body.
Research at the Washington Cancer Institute
The Washington Cancer Institute is committed to providing state-of-the-art and emerging technologies that deliver the latest, safest and most effective cancer treatments. The center includes new therapies offered through clinical trials if possible.
Experts at the Washington Cancer Institute encourage patients to participate in clinical trials to evaluate the safety and effectiveness of promising treatment approaches.
There is no guarantee that new treatments from clinical trials will be better than those that already exist, but it’s a chance to gain access to innovative options that are not otherwise available.
The Washington Cancer Institute accepts most managed care and commercial health insurance. Forms of payment also include all major credit cards, cash and checks.
The administrative staff is available to assist patients with the necessary insurance and referral requirements. In case of questions or need of more information, contact billing and records at 800-280-9006.
Seeking Treatment at Washington Cancer Institute
The Washington Cancer Institute is a world-renowned center for mesothelioma treatment, particularly peritoneal mesothelioma. An innovative surgical technique by one of the top peritoneal mesothelioma surgeons has extended the lives of countless patients.
The Washington Cancer Institute is dedicated to providing the most comprehensive and patient-centered care while striving to utilize the most technologically-advanced techniques. This center strives for excellence in clinical care by promoting a healing environment and providing compassion and support before, during and after treatment.
For more information on working with the experts at the Washington Cancer Institute, contact us today. Our Justice Support Team can match you with doctors across the country specializing in your exact diagnosis.